Unknown

Dataset Information

0

WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit.


ABSTRACT: The dysregulation of transcription factors is widely associated with tumorigenesis. As the most well-defined transcription factor in multiple types of cancer, c-Myc can transform cells by transactivating various downstream genes. Given that there is no effective way to directly inhibit c-Myc, c-Myc targeting strategies hold great potential for cancer therapy. In this study, we found that WSB1, which has a highly positive correlation with c-Myc in 10 cancer cell lines and clinical samples, is a direct target gene of c-Myc, and can positively regulate c-Myc expression, which forms a feedforward circuit promoting cancer development. RNA sequencing results from Bel-7402 cells confirmed that WSB1 promoted c-Myc expression through the β-catenin pathway. Mechanistically, WSB1 affected β-catenin destruction complex-PPP2CA assembly and E3 ubiquitin ligase adaptor β-TRCP recruitment, which inhibited the ubiquitination of β-catenin and transactivated c-Myc. Of interest, the effect of WSB1 on c-Myc was independent of its E3 ligase activity. Moreover, overexpressing WSB1 in the Bel-7402 xenograft model could further strengthen the tumor-driven effect of c-Myc overexpression. Thus, our findings revealed a novel mechanism involved in tumorigenesis in which the WSB1/c-Myc feedforward circuit played an essential role, highlighting a potential c-Myc intervention strategy in cancer treatment.

SUBMITTER: Gao X 

PROVIDER: S-EPMC9072231 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

WSB1 regulates c-Myc expression through <i>β</i>-catenin signaling and forms a feedforward circuit.

Gao Xiaomeng X   You Jieqiong J   Gong Yanling Y   Yuan Meng M   Zhu Haiying H   Fang Liang L   Zhu Hong H   Ying Meidan M   He Qiaojun Q   Yang Bo B   Cao Ji J  

Acta pharmaceutica Sinica. B 20211026 3


The dysregulation of transcription factors is widely associated with tumorigenesis. As the most well-defined transcription factor in multiple types of cancer, c-Myc can transform cells by transactivating various downstream genes. Given that there is no effective way to directly inhibit c-Myc, c-Myc targeting strategies hold great potential for cancer therapy. In this study, we found that WSB1, which has a highly positive correlation with c-Myc in 10 cancer cell lines and clinical samples, is a d  ...[more]

Similar Datasets

2021-10-01 | GSE182635 | GEO
| PRJNA757243 | ENA
| S-EPMC7206793 | biostudies-literature
| S-EPMC8817551 | biostudies-literature
| S-EPMC2859189 | biostudies-literature
| S-EPMC8100484 | biostudies-literature
| S-EPMC10893653 | biostudies-literature
| S-EPMC3754916 | biostudies-literature
| S-EPMC11465819 | biostudies-literature
| S-EPMC4529819 | biostudies-literature